Industry Research Reports

Home > Reports > Service & Software > Pet Stem Cells- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Pet Stem Cells- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Service & Software

Published Date: 2025-02-20

Pages: 81 Pages

Report ld: 4023456

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Pet Stem Cells was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

Stem cells can differentiate into blood vessel, bone, heart, cartilage, fat, ligament, liver, muscle, nerve and tendon tissue. Stem cells can currently be obtained from bone marrow and adipose (fat) tissues of dogs, cats and horses. The most common use of stem cell therapy is to treat osteoarthritis in dogs and cats. Other potential uses include repairing bone, ligament and spinal cord injuries, as well as treating kidney and liver diseases, cardiomyopathy (a type of heart disease), and certain skin and intestinal inflammatory diseases.

The global pet stem cells market is experiencing steady growth driven by the demand for advanced regenerative therapies in pet healthcare. The market is competitive, with various companies offering stem cell therapy products and services for pets. As the field of veterinary biotechnology continues to evolve, the use of stem cells in pet healthcare is expected to expand further.

This report aims to provide a comprehensive presentation of the global market for Pet Stem Cells, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Pet Stem Cells by region & country, by Type, and by Application.

The Pet Stem Cells market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Stem Cells.

MARKET SEGMENTATION

By Company

VetStem, Inc.
Gallant Therapeutics
Medrego
Royal Veterinary College
Ardent Animal Health
Marina Village Veterinary
Boehringer Ingelheim
Cell Therapy Sciences
Vet4Bulldog
Biobest

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Embryonic Stem Cells (ESCs)
Hematopoietic Stem Cells
Mesenchymal Stem Cells

Segment by Application

Dog
Cat
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Pet Stem Cells company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Pet Stem Cells in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Pet Stem Cells in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Pet Stem Cells Product Introduction

1.2 Global Pet Stem Cells Market Size Forecast (2020-2031)

1.3 Pet Stem Cells Market Trends & Drivers

1.3.1 Pet Stem Cells Industry Trends

1.3.2 Pet Stem Cells Market Drivers & Opportunity

1.3.3 Pet Stem Cells Market Challenges

1.3.4 Pet Stem Cells Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Pet Stem Cells Players Revenue Ranking (2024)

2.2 Global Pet Stem Cells Revenue by Company (2020-2025)

2.3 Key Companies Pet Stem Cells Manufacturing Base Distribution and Headquarters

2.4 Key Companies Pet Stem Cells Product Offered

2.5 Key Companies Time to Begin Mass Production of Pet Stem Cells

2.6 Pet Stem Cells Market Competitive Analysis

2.6.1 Pet Stem Cells Market Concentration Rate (2020-2025)

2.6.2 Global 5 and 10 Largest Companies by Pet Stem Cells Revenue in 2024

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Stem Cells as of 2024)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Embryonic Stem Cells (ESCs)

3.1.2 Hematopoietic Stem Cells

3.1.3 Mesenchymal Stem Cells

3.2 Global Pet Stem Cells Sales Value by Type

3.2.1 Global Pet Stem Cells Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Pet Stem Cells Sales Value, by Type (2020-2031)

3.2.3 Global Pet Stem Cells Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Dog

4.1.2 Cat

4.1.3 Others

4.2 Global Pet Stem Cells Sales Value by Application

4.2.1 Global Pet Stem Cells Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Pet Stem Cells Sales Value, by Application (2020-2031)

4.2.3 Global Pet Stem Cells Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

5.1 Global Pet Stem Cells Sales Value by Region

5.1.1 Global Pet Stem Cells Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Pet Stem Cells Sales Value by Region (2020-2025)

5.1.3 Global Pet Stem Cells Sales Value by Region (2026-2031)

5.1.4 Global Pet Stem Cells Sales Value by Region (%), (2020-2031)

5.2 North America

5.2.1 North America Pet Stem Cells Sales Value, 2020-2031

5.2.2 North America Pet Stem Cells Sales Value by Country (%), 2024 VS 2031

5.3 Europe

5.3.1 Europe Pet Stem Cells Sales Value, 2020-2031

5.3.2 Europe Pet Stem Cells Sales Value by Country (%), 2024 VS 2031

5.4 Asia Pacific

5.4.1 Asia Pacific Pet Stem Cells Sales Value, 2020-2031

5.4.2 Asia Pacific Pet Stem Cells Sales Value by Region (%), 2024 VS 2031

5.5 South America

5.5.1 South America Pet Stem Cells Sales Value, 2020-2031

5.5.2 South America Pet Stem Cells Sales Value by Country (%), 2024 VS 2031

5.6 Middle East & Africa

5.6.1 Middle East & Africa Pet Stem Cells Sales Value, 2020-2031

5.6.2 Middle East & Africa Pet Stem Cells Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Pet Stem Cells Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Pet Stem Cells Sales Value, 2020-2031

6.3 United States

6.3.1 United States Pet Stem Cells Sales Value, 2020-2031

6.3.2 United States Pet Stem Cells Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Pet Stem Cells Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Pet Stem Cells Sales Value, 2020-2031

6.4.2 Europe Pet Stem Cells Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Pet Stem Cells Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Pet Stem Cells Sales Value, 2020-2031

6.5.2 China Pet Stem Cells Sales Value by Type (%), 2024 VS 2031

6.5.3 China Pet Stem Cells Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Pet Stem Cells Sales Value, 2020-2031

6.6.2 Japan Pet Stem Cells Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Pet Stem Cells Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Pet Stem Cells Sales Value, 2020-2031

6.7.2 South Korea Pet Stem Cells Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Pet Stem Cells Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Pet Stem Cells Sales Value, 2020-2031

6.8.2 Southeast Asia Pet Stem Cells Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Pet Stem Cells Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Pet Stem Cells Sales Value, 2020-2031

6.9.2 India Pet Stem Cells Sales Value by Type (%), 2024 VS 2031

6.9.3 India Pet Stem Cells Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 VetStem, Inc.

7.1.1 VetStem, Inc. Profile

7.1.2 VetStem, Inc. Main Business

7.1.3 VetStem, Inc. Pet Stem Cells Products, Services and Solutions

7.1.4 VetStem, Inc. Pet Stem Cells Revenue (US$ Million) & (2020-2025)

7.1.5 VetStem, Inc. Recent Developments

7.2 Gallant Therapeutics

7.2.1 Gallant Therapeutics Profile

7.2.2 Gallant Therapeutics Main Business

7.2.3 Gallant Therapeutics Pet Stem Cells Products, Services and Solutions

7.2.4 Gallant Therapeutics Pet Stem Cells Revenue (US$ Million) & (2020-2025)

7.2.5 Gallant Therapeutics Recent Developments

7.3 Medrego

7.3.1 Medrego Profile

7.3.2 Medrego Main Business

7.3.3 Medrego Pet Stem Cells Products, Services and Solutions

7.3.4 Medrego Pet Stem Cells Revenue (US$ Million) & (2020-2025)

7.3.5 Medrego Recent Developments

7.4 Royal Veterinary College

7.4.1 Royal Veterinary College Profile

7.4.2 Royal Veterinary College Main Business

7.4.3 Royal Veterinary College Pet Stem Cells Products, Services and Solutions

7.4.4 Royal Veterinary College Pet Stem Cells Revenue (US$ Million) & (2020-2025)

7.4.5 Royal Veterinary College Recent Developments

7.5 Ardent Animal Health

7.5.1 Ardent Animal Health Profile

7.5.2 Ardent Animal Health Main Business

7.5.3 Ardent Animal Health Pet Stem Cells Products, Services and Solutions

7.5.4 Ardent Animal Health Pet Stem Cells Revenue (US$ Million) & (2020-2025)

7.5.5 Ardent Animal Health Recent Developments

7.6 Marina Village Veterinary

7.6.1 Marina Village Veterinary Profile

7.6.2 Marina Village Veterinary Main Business

7.6.3 Marina Village Veterinary Pet Stem Cells Products, Services and Solutions

7.6.4 Marina Village Veterinary Pet Stem Cells Revenue (US$ Million) & (2020-2025)

7.6.5 Marina Village Veterinary Recent Developments

7.7 Boehringer Ingelheim

7.7.1 Boehringer Ingelheim Profile

7.7.2 Boehringer Ingelheim Main Business

7.7.3 Boehringer Ingelheim Pet Stem Cells Products, Services and Solutions

7.7.4 Boehringer Ingelheim Pet Stem Cells Revenue (US$ Million) & (2020-2025)

7.7.5 Boehringer Ingelheim Recent Developments

7.8 Cell Therapy Sciences

7.8.1 Cell Therapy Sciences Profile

7.8.2 Cell Therapy Sciences Main Business

7.8.3 Cell Therapy Sciences Pet Stem Cells Products, Services and Solutions

7.8.4 Cell Therapy Sciences Pet Stem Cells Revenue (US$ Million) & (2020-2025)

7.8.5 Cell Therapy Sciences Recent Developments

7.9 Vet4Bulldog

7.9.1 Vet4Bulldog Profile

7.9.2 Vet4Bulldog Main Business

7.9.3 Vet4Bulldog Pet Stem Cells Products, Services and Solutions

7.9.4 Vet4Bulldog Pet Stem Cells Revenue (US$ Million) & (2020-2025)

7.9.5 Vet4Bulldog Recent Developments

7.10 Biobest

7.10.1 Biobest Profile

7.10.2 Biobest Main Business

7.10.3 Biobest Pet Stem Cells Products, Services and Solutions

7.10.4 Biobest Pet Stem Cells Revenue (US$ Million) & (2020-2025)

7.10.5 Biobest Recent Developments

8 Industry Chain Analysis

8.1 Pet Stem Cells Industrial Chain

8.2 Pet Stem Cells Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Pet Stem Cells Sales Model

8.5.2 Sales Channel

8.5.3 Pet Stem Cells Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Pet Stem Cells Market Trends

Table 2. Pet Stem Cells Market Drivers & Opportunity

Table 3. Pet Stem Cells Market Challenges

Table 4. Pet Stem Cells Market Restraints

Table 5. Global Pet Stem Cells Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Pet Stem Cells Revenue Market Share by Company (2020-2025)

Table 7. Key Companies Pet Stem Cells Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Pet Stem Cells Product Type

Table 9. Key Companies Time to Begin Mass Production of Pet Stem Cells

Table 10. Global Pet Stem Cells Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Stem Cells as of 2024)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Pet Stem Cells Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 14. Global Pet Stem Cells Sales Value by Type (2020-2025) & (US$ Million)

Table 15. Global Pet Stem Cells Sales Value by Type (2026-2031) & (US$ Million)

Table 16. Global Pet Stem Cells Sales Market Share in Value by Type (2020-2025)

Table 17. Global Pet Stem Cells Sales Market Share in Value by Type (2026-2031)

Table 18. Global Pet Stem Cells Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 19. Global Pet Stem Cells Sales Value by Application (2020-2025) & (US$ Million)

Table 20. Global Pet Stem Cells Sales Value by Application (2026-2031) & (US$ Million)

Table 21. Global Pet Stem Cells Sales Market Share in Value by Application (2020-2025)

Table 22. Global Pet Stem Cells Sales Market Share in Value by Application (2026-2031)

Table 23. Global Pet Stem Cells Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 24. Global Pet Stem Cells Sales Value by Region (2020-2025) & (US$ Million)

Table 25. Global Pet Stem Cells Sales Value by Region (2026-2031) & (US$ Million)

Table 26. Global Pet Stem Cells Sales Value by Region (2020-2025) & (%)

Table 27. Global Pet Stem Cells Sales Value by Region (2026-2031) & (%)

Table 28. Key Countries/Regions Pet Stem Cells Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 29. Key Countries/Regions Pet Stem Cells Sales Value, (2020-2025) & (US$ Million)

Table 30. Key Countries/Regions Pet Stem Cells Sales Value, (2026-2031) & (US$ Million)

Table 31. VetStem, Inc. Basic Information List

Table 32. VetStem, Inc. Description and Business Overview

Table 33. VetStem, Inc. Pet Stem Cells Products, Services and Solutions

Table 34. Revenue (US$ Million) in Pet Stem Cells Business of VetStem, Inc. (2020-2025)

Table 35. VetStem, Inc. Recent Developments

Table 36. Gallant Therapeutics Basic Information List

Table 37. Gallant Therapeutics Description and Business Overview

Table 38. Gallant Therapeutics Pet Stem Cells Products, Services and Solutions

Table 39. Revenue (US$ Million) in Pet Stem Cells Business of Gallant Therapeutics (2020-2025)

Table 40. Gallant Therapeutics Recent Developments

Table 41. Medrego Basic Information List

Table 42. Medrego Description and Business Overview

Table 43. Medrego Pet Stem Cells Products, Services and Solutions

Table 44. Revenue (US$ Million) in Pet Stem Cells Business of Medrego (2020-2025)

Table 45. Medrego Recent Developments

Table 46. Royal Veterinary College Basic Information List

Table 47. Royal Veterinary College Description and Business Overview

Table 48. Royal Veterinary College Pet Stem Cells Products, Services and Solutions

Table 49. Revenue (US$ Million) in Pet Stem Cells Business of Royal Veterinary College (2020-2025)

Table 50. Royal Veterinary College Recent Developments

Table 51. Ardent Animal Health Basic Information List

Table 52. Ardent Animal Health Description and Business Overview

Table 53. Ardent Animal Health Pet Stem Cells Products, Services and Solutions

Table 54. Revenue (US$ Million) in Pet Stem Cells Business of Ardent Animal Health (2020-2025)

Table 55. Ardent Animal Health Recent Developments

Table 56. Marina Village Veterinary Basic Information List

Table 57. Marina Village Veterinary Description and Business Overview

Table 58. Marina Village Veterinary Pet Stem Cells Products, Services and Solutions

Table 59. Revenue (US$ Million) in Pet Stem Cells Business of Marina Village Veterinary (2020-2025)

Table 60. Marina Village Veterinary Recent Developments

Table 61. Boehringer Ingelheim Basic Information List

Table 62. Boehringer Ingelheim Description and Business Overview

Table 63. Boehringer Ingelheim Pet Stem Cells Products, Services and Solutions

Table 64. Revenue (US$ Million) in Pet Stem Cells Business of Boehringer Ingelheim (2020-2025)

Table 65. Boehringer Ingelheim Recent Developments

Table 66. Cell Therapy Sciences Basic Information List

Table 67. Cell Therapy Sciences Description and Business Overview

Table 68. Cell Therapy Sciences Pet Stem Cells Products, Services and Solutions

Table 69. Revenue (US$ Million) in Pet Stem Cells Business of Cell Therapy Sciences (2020-2025)

Table 70. Cell Therapy Sciences Recent Developments

Table 71. Vet4Bulldog Basic Information List

Table 72. Vet4Bulldog Description and Business Overview

Table 73. Vet4Bulldog Pet Stem Cells Products, Services and Solutions

Table 74. Revenue (US$ Million) in Pet Stem Cells Business of Vet4Bulldog (2020-2025)

Table 75. Vet4Bulldog Recent Developments

Table 76. Biobest Basic Information List

Table 77. Biobest Description and Business Overview

Table 78. Biobest Pet Stem Cells Products, Services and Solutions

Table 79. Revenue (US$ Million) in Pet Stem Cells Business of Biobest (2020-2025)

Table 80. Biobest Recent Developments

Table 81. Key Raw Materials Lists

Table 82. Raw Materials Key Suppliers Lists

Table 83. Pet Stem Cells Downstream Customers

Table 84. Pet Stem Cells Distributors List

Table 85. Research Programs/Design for This Report

Table 86. Key Data Information from Secondary Sources

Table 87. Key Data Information from Primary Sources

Table 88. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Pet Stem Cells Product Picture

Figure 2. Global Pet Stem Cells Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Pet Stem Cells Sales Value (2020-2031) & (US$ Million)

Figure 4. Pet Stem Cells Report Years Considered

Figure 5. Global Pet Stem Cells Players Revenue Ranking (2024) & (US$ Million)

Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Pet Stem Cells Revenue in 2024

Figure 7. Pet Stem Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 8. Embryonic Stem Cells (ESCs) Picture

Figure 9. Hematopoietic Stem Cells Picture

Figure 10. Mesenchymal Stem Cells Picture

Figure 11. Global Pet Stem Cells Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 12. Global Pet Stem Cells Sales Value Market Share by Type, 2024 & 2031

Figure 13. Product Picture of Dog

Figure 14. Product Picture of Cat

Figure 15. Product Picture of Others

Figure 16. Global Pet Stem Cells Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 17. Global Pet Stem Cells Sales Value Market Share by Application, 2024 & 2031

Figure 18. North America Pet Stem Cells Sales Value (2020-2031) & (US$ Million)

Figure 19. North America Pet Stem Cells Sales Value by Country (%), 2024 VS 2031

Figure 20. Europe Pet Stem Cells Sales Value, (2020-2031) & (US$ Million)

Figure 21. Europe Pet Stem Cells Sales Value by Country (%), 2024 VS 2031

Figure 22. Asia Pacific Pet Stem Cells Sales Value, (2020-2031) & (US$ Million)

Figure 23. Asia Pacific Pet Stem Cells Sales Value by Region (%), 2024 VS 2031

Figure 24. South America Pet Stem Cells Sales Value, (2020-2031) & (US$ Million)

Figure 25. South America Pet Stem Cells Sales Value by Country (%), 2024 VS 2031

Figure 26. Middle East & Africa Pet Stem Cells Sales Value, (2020-2031) & (US$ Million)

Figure 27. Middle East & Africa Pet Stem Cells Sales Value by Country (%), 2024 VS 2031

Figure 28. Key Countries/Regions Pet Stem Cells Sales Value (%), (2020-2031)

Figure 29. United States Pet Stem Cells Sales Value, (2020-2031) & (US$ Million)

Figure 30. United States Pet Stem Cells Sales Value by Type (%), 2024 VS 2031

Figure 31. United States Pet Stem Cells Sales Value by Application (%), 2024 VS 2031

Figure 32. Europe Pet Stem Cells Sales Value, (2020-2031) & (US$ Million)

Figure 33. Europe Pet Stem Cells Sales Value by Type (%), 2024 VS 2031

Figure 34. Europe Pet Stem Cells Sales Value by Application (%), 2024 VS 2031

Figure 35. China Pet Stem Cells Sales Value, (2020-2031) & (US$ Million)

Figure 36. China Pet Stem Cells Sales Value by Type (%), 2024 VS 2031

Figure 37. China Pet Stem Cells Sales Value by Application (%), 2024 VS 2031

Figure 38. Japan Pet Stem Cells Sales Value, (2020-2031) & (US$ Million)

Figure 39. Japan Pet Stem Cells Sales Value by Type (%), 2024 VS 2031

Figure 40. Japan Pet Stem Cells Sales Value by Application (%), 2024 VS 2031

Figure 41. South Korea Pet Stem Cells Sales Value, (2020-2031) & (US$ Million)

Figure 42. South Korea Pet Stem Cells Sales Value by Type (%), 2024 VS 2031

Figure 43. South Korea Pet Stem Cells Sales Value by Application (%), 2024 VS 2031

Figure 44. Southeast Asia Pet Stem Cells Sales Value, (2020-2031) & (US$ Million)

Figure 45. Southeast Asia Pet Stem Cells Sales Value by Type (%), 2024 VS 2031

Figure 46. Southeast Asia Pet Stem Cells Sales Value by Application (%), 2024 VS 2031

Figure 47. India Pet Stem Cells Sales Value, (2020-2031) & (US$ Million)

Figure 48. India Pet Stem Cells Sales Value by Type (%), 2024 VS 2031

Figure 49. India Pet Stem Cells Sales Value by Application (%), 2024 VS 2031

Figure 50. Pet Stem Cells Industrial Chain

Figure 51. Pet Stem Cells Manufacturing Cost Structure

Figure 52. Channels of Distribution (Direct Sales, and Distribution)

Figure 53. Bottom-up and Top-down Approaches for This Report

Figure 54. Data Triangulation

Figure 55. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Pet Stem Cells market? zhanKai

The top companies in the global Pet Stem Cells market are VetStem, Inc.、Gallant Therapeutics、Medrego.

Related Reports

Pet Stem Cells - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pet Stem Cells was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 109
USD 3950.00
(Single User License)
Global Pet Stem Cells Market Research Report 2026
The global Pet Stem Cells market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 102
USD 2900.00
(Single User License)
Global Pet Stem Cells Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Pet Stem Cells market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-23
Pages: 127
USD 4900.00
(Single User License)
Global Pet Stem Cells Market Research Report 2025
The global market for Pet Stem Cells was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-20
Pages: 78
USD 2900.00
(Single User License)
Global Pet Stem Cells Market Insights, Forecast to 2030
Stem cells can differentiate into blood vessel, bone, heart, cartilage, fat, ligament, liver, muscle, nerve and tendon tissue. Stem cells can currently be obtained from bone marrow and adipose (fat) tissues of dogs, cats and horses. The most common use of stem cell therapy is to treat osteoarthritis in dogs and cats. Other potential uses include repairing bone, ligament and spinal cord injuries, as well as treating kidney and liver diseases, cardiomyopathy (a type of heart disease), and certain skin and intestinal inflammatory diseases.
Published Date: 2024-04-07
Pages: 107
USD 4900.00
(Single User License)

Pet Stem Cells - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pet Stem Cells was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 109
USD 3950.00 (Single User License)
Global Pet Stem Cells Market Research Report 2026
The global Pet Stem Cells market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 102
USD 2900.00 (Single User License)
Global Pet Stem Cells Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Pet Stem Cells market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-23
Pages: 127
USD 4900.00 (Single User License)
Global Pet Stem Cells Market Research Report 2025
The global market for Pet Stem Cells was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-20
Pages: 78
USD 2900.00 (Single User License)
Global Pet Stem Cells Market Insights, Forecast to 2030
Stem cells can differentiate into blood vessel, bone, heart, cartilage, fat, ligament, liver, muscle, nerve and tendon tissue. Stem cells can currently be obtained from bone marrow and adipose (fat) tissues of dogs, cats and horses. The most common use of stem cell therapy is to treat osteoarthritis in dogs and cats. Other potential uses include repairing bone, ligament and spinal cord injuries, as well as treating kidney and liver diseases, cardiomyopathy (a type of heart disease), and certain skin and intestinal inflammatory diseases.
Published: 2024-04-07
Pages: 107
USD 4900.00 (Single User License)